10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 10-Q

[ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2017

OR

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________ to ___________

Commission file number: 000-54793

JPX GLOBAL, INC.

(Name of Small Business Issuer in Its Charter)

Nevada	26-2801338
(State or Other Jurisdiction of Incorporation or Organization)	(IRS Employer Identification No.)
11650 South State Street, Ste. 240
Draper, UT	84020
(Address of Principal Executive Offices)	(Zip Code)

	(801) 816-2533
	(Issuer’s Telephone Number)
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer,” and “smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer [  ]	Accelerated Filer [  ]
Non-Accelerated Filer [  ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant has filed all documents and reports required to be filed by Sections 12, 13, or 15(d) of the Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes [ ] No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date. As of March 21, 2018, the Company had outstanding 214,043,596 shares of common stock, par value $0.001 per share.

2

JPX GLOBAL, INC.

QUARTERLY PERIOD ENDED SEPTEMBER 30, 2017

Index to Report on Form 10-Q

		Page No.
	PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements	4
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	16
Item 4T.	Controls and Procedures	16
	PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	18
Item 1A.	Risk Factors	18
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	18
Item 3.	Defaults Upon Senior Securities	18
Item 4.	Mine Safety Disclosures	18
Item 5.	Other Information	18
Item 6.	Exhibits	19
	Signatures	20

3

JPX GLOBAL, INC.
Balance Sheets
ASSETS
	September 30,			December 31,
	2017			2016
	(Unaudited)
CURRENT ASSETS
Cash and cash equivalents	$	187		$	583
Total Current Assets		187			583
TOTAL ASSETS	$	187		$	583
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued liabilities	$	79,818		$	47,989
Advances from related parties		21,594			14,594
Notes payable to related parties		184,864			171,864
Notes payable		258,328			148,146
Convertible loan payable - related party		1,500			1,500
Derivative liability		265,144			724,364
Total Current Liabilities		811,248			1,108,457
TOTAL LIABILITIES		811,248			1,108,457
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value; 40,000,000 shares authorized:
Series A Preferred Stock, $0.001 par value; 1,000 and
1,000 shares issued and outstanding, respectively		1			1
Series B Preferred Stock, $0.001 par value; 10,000,000 and
10,000,000 shares issued and outstanding, respectively		10,000			10,000
Common stock, $0.001 par value; 1,500,000,000 shares authorized,
214,043,596 and 171,789,142 shares issued and outstanding, respectively		214,043			171,789
Additional paid-in capital		33,454,201			33,468,361
Accumulated deficit		(34,489,306	)		(34,758,025	)
Total Stockholders' Deficit		(811,061	)		(1,107,874	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	187		$	583
The accompanying notes are an integral part of these financial statements

4

JPX GLOBAL, INC.
Statements of Operations
(Unaudited)
	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2017			2016			2017			2016
NET REVENUES	$	—		$	—		$	—		$	—
OPERATING EXPENSES
Consulting fees (including stock-based compensation of
$-0-, $-0-, $-0- and $600,000, respectively)		—			30,000			—			630,000
Professional and accounting fees		12,279			90,105			37,293			113,313
Other general and administrative		132			21,038			396			21,832
Total Operating Expenses		12,411			141,143			37,689			765,145
LOSS FROM OPERATIONS		(12,411	)		(141,143	)		(37,689	)		(765,145	)
OTHER INCOME (EXPENSES)
Income (loss) from derivative liability		15,451			(127,971	)		459,219			(127,971	)
Interest expense (including the amortization of debt discounts
of $-0-, $42,409, $67,854 and $42,409, respectively)		(63,253	)		(51,208	)		(152,811	)		(51,994	)
Total Other Income (Expenses)		(47,802	)		(179,179	)		306,408			(179,965	)
NET INCOME (LOSS)	$	(60,213	)	$	(320,322	)	$	268,719		$	(945,110	)
Net income (loss) per common share - basic and diluted	$	(0.00	)	$	(0.00	)	$	0.00		$	(0.01	)
Weighted average common shares outstanding:
Basic		214,043,596			170,455,809			204,520,333			168,733,181
Diluted		214,043,596			170,455,809			542,756,310			168,733,181
The accompanying notes are an integral part of these financial statements

5

JPX GLOBAL, INC.
Statements of Cash Flows
(Unaudited)
	For the Nine Months Ended
	September 30,
	2017			2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	268,719		$	(945,110	)
Adjustments to reconcile net loss to net
cash used by operating activities:
Common stock issued for services		—			600,000
Note payable issued for legal services		—			50,000
Default fees added to notes payable		54,000			—
Amortization of debt discount		67,854			42,409
Expense (income) from derivative liability		(459,219	)		127,971
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities		48,250			8,427
Net Cash Used by Operating Activities		(20,396	)		(116,303	)
CASH FLOWS FROM INVESTING ACTIVITIES:		—			—
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from note payable		—			166,000
Proceeds from notes payable to related party		13,000			5,000
Proceeds from advances from related party		7,000			11,500
Payments on note payable to related party		—			(66,200	)
Net Cash Provided by Financing Activities		20,000			116,300
NET DECREASE IN CASH AND CASH EQUIVALENTS		(396	)		(3	)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		583			83
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	187		$	80
SUPPLEMENTAL CASH FLOW INFORMATION
Cash Payments For:
Interest	$	—		$	—
Taxes	$	—		$	—
Non-cash financing activities:
Common stock issued for services	$	—		$	600,000
Issuance of note payable to related party in satisfaction of
advances from related party liability	$	—		$	254,364
Issuance of common stock in satisfaction
of notes payable and accrued interest	$	28,094		$	—
The accompanying notes are an integral part of these financial statements

6

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

NOTE 1 - ORGANIZATION

JPX Global, Inc. (the “Company” or “JPX”) was incorporated under the laws of the state of Nevada on December 18, 2008, with 75,000,000 authorized common shares with a par value of $0.001. On January 3, 2013, the Company approved the action to amend and restate the Articles of Incorporation of the Company and increase the authorized common shares to 500,000,000 and create and authorize 40,000,000 shares of Preferred Stock which was approved by written consent of the holders representing approximately 67% of the outstanding voting securities of the Company. Series A Preferred Stock was created and designated with super-voting rights of 100,000 votes per share of Series A Preferred Stock held, but no conversion, dividend and liquidation rights. On July 12, 2017, the Company amended the Certificate of Designations, Preferences, Rights and Limitations of Series A Preferred Stock to change the voting rights of each share of Series A Preferred Stock to equal four times the sum of all shares of common stock issued and outstanding at time of voting plus the total number of votes of all other classes of preferred stock which are issued and outstanding at the time of voting divided by the number of shares of Series A Preferred Stock issued and outstanding at the time of voting. On August 29, 2017, the Company amended its Articles of Incorporation to increase the authorized common shares to 1,500,000,000 shares.

On February 5, 2014, the Company entered into an agreement to acquire all the operating assets of Scorpex, Inc. (“Scorpex”) (an entity related by common control) in exchange for 105,000,000 shares of common stock and 10,000,000 shares of Series B Preferred Stock of the Company. Scorpex was majority owned and controlled by JPX Global, Inc.’s then controlling shareholder, Joseph Caywood. Each share of Series B preferred stock is convertible into 10 shares of common stock and is entitled to vote ratably together with our common stockholders on all matters upon which common stockholders may vote. With the acquisition of these assets, which consist primarily of a license agreement, the Company modified its business plan to include the development of waste management services including the storage, recycling, and disposal of waste.  The Company does not presently have any waste management operations.

The acquired assets consist primarily of a license agreement between Scorpex and TratamientosAmbientales Scorpion, S.A. de C.V. (a corporation formed under the laws of Mexico) (“TAS”). This license agreement with TAS was assigned to JPX. TAS was a wholly owned subsidiary of Scorpex, and was, therefore, a common control entity. ASC 805-50-30-5 provides guidance on measuring assets and liabilities transferred between entities under common control. As these entities were under common control and the license agreement had no basis on Scorpex’s books, the transaction was recorded at a value of $-0-.

The license agreement was dated July 30, 2011 and provided Scorpex with an exclusive worldwide license for the permits, property, and any and all of TAS’s other assets necessary for the business of storing, recycling, disposing, and treating waste in Mexico for a term of 10 years. The agreement also provided for Scorpex’s annual payment to TAS of 20% of its Net Revenues (gross cash receipts less cost of processing and other expenses excluding general, administrative, interest, and taxes) from the license. Pursuant to the Assignment Consent dated February 3, 2014, TAS agreed to extend the term of the agreement every 10 years if operations have commenced pursuant to the license agreement.

7

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

NOTE 2 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its Form 10-K for the year ended December 31, 2016. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017.

NOTE 3 - GOING CONCERN

The accompanying financial statements have been prepared assuming that the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. At September 30, 2017, the Company had $187 cash, negative working capital of $811,061 (including past due debt), and no business operations. These conditions raise substantial doubt about our ability to meet our future financial obligations as they become due within one year after the date that the financial statements are issued.

Continuation of the company as a going concern is dependent upon obtaining additional working capital and the management of the company plans to accomplish this objective through short term loans from related parties and additional equity investments, which will enable the company to continue operations for the coming year. However, no financing arrangements have yet been implemented. Therefore, these plans do not alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year after the date that the financial statements are issued.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from the outcome of this uncertainty.

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE

The Company follows ASC Topic 260 to account for earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share calculations are determined by dividing net income (loss) by the weighted average number of common shares and dilutive common share equivalents outstanding.

8

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

For the periods presented, the common shares underlying the following dilutive securities were excluded from the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive:

	Common Shares Issuable
	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2016
Convertible note payable		236,735,977		6,036,364		6,036,364
Convertible loan payable – related party		1,500,000		1,500,000		1,500,000
Series B Preferred Stock		100,000,000		100,000,000		100,000,000
Total common shares issuable		338,235,977		107,536,364		107,536,364

NOTE 5 - ADVANCES FROM RELATED PARTIES

The advances from related parties liability at September 30, 2017 ($21,594) and December 31, 2016 ($14,594) are due to Joseph Caywood, former chief executive officer and significant stockholder of the Company, and John D. Thomas PC, legal counsel of the Company. The liabilities are non-interest bearing and there are no terms of repayment.

On July 1, 2016, the Company issued a $254,364 Promissory Note to Joseph Caywood in satisfaction of the then advances from related party liability of $254,364. See Note 6.

9

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES

The notes payable to related parties at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017		December 31, 2016
Promissory note dated May 20, 2015, interest at 8% per annum, interest and principal due November 20, 2015 (A)	$	8,000	$	8,000
Promissory note dated June 24, 2015, interest at 8% per annum, interest and principal due December 24, 2015 (A)		8,000		8,000
Promissory note dated November 15, 2015, interest at 8% per annum, interest and principal due May 15, 2016 (A)		2,000		2,000
Promissory note dated April 15, 2016, interest at 8% per annum, interest and principal due October 12, 2016 (A)		3,000		3,000
Promissory note dated May 21, 2016, interest at 8% per annum, interest and principal due November 17, 2016 (A)		2,000		2,000
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		148,864		148,864
Promissory note dated August 9, 2017, interest at 8% per annum, interest and principal due February 9, 2019 (A)		6,500		—
Promissory note dated September 8, 2017, interest at 8% per annum, interest and principal due March 8, 2019 (A)		6,500		—
Total	$	184,864	$	171,864

(A) These notes are payable to Mitchell Dean Hovendick, owner of 1,000 shares of Series A Preferred Stock, 10,000,000 shares of Series B Preferred Stock, and 75,250,000 shares of common stock.

(B) This note is payable to Joseph Caywood, former owner of 500 shares of Series A Preferred Stock, 5,000,000 shares of Series B Preferred Stock, and 37,625,000 shares of common stock. The original note was in the amount of $254,364 and arose from the Company’s satisfaction of the then advances from related party liability of $254,364 (See Note 5). From July 1, 2016 to December 31, 2016, the Company repaid $105,500 of the note.

10

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

NOTE 7 – NOTES PAYABLE

The notes payable at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017		December  31, 2016
Convertible note payable dated July 22, 2016, interest at 10% due on April 22, 2017 – net of discount of $-0- and $67,854, respectively (A)	$	208,328	$	98,146
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		50,000		50,000
Total	$	258,328	$	148,146

(A) On July 22, 2016, the Company issued a $166,000 Convertible Promissory Note to Auctus Fund, LLC (“Auctus”) for net loan proceeds of $150,000. The note bears interest at a rate of 10% per annum (24% per annum default rate), is due April 22, 2017, and is convertible at the option of Auctus into shares of the Company common stock at a Conversion Price equal to the lesser of (a) 55% of the lowest Trading Price during the 25 Trading Day period prior to July 22, 2016 or (b) 55% of the lowest Trading Price during the 25 Trading Day period prior to the Conversion Date. See Note 9 – Derivative Liability. On August 8, 2017, the Company entered into a Settlement Agreement and Mutual General Release with Auctus. The agreement provided for a $54,000 increase of the outstanding principal balance of the Note (from $154,328 to $208,328). The agreement also provided for the Company’s issuance of an irrevocable letter of instruction to its transfer agent to reserve initially 933,333,334 shares of common stock for conversion of the Amended Note.

(B) This note is payable to the Company’s law firm for legal services rendered.

NOTE 8 - CONVERTIBLE LOAN PAYABLE - RELATED PARTY

On December 18, 2008, the Company entered into a Promissory Note agreement with a former CEO of the Company. The note is for a sum of $1,500, is non interest bearing, and was due and payable on December 31, 2010. The note provides that if the note was not paid on December 31, 2010, the note can be converted to shares of common stock of the Company for $.001 per share. On January 3, 2013, this note was assigned to Joseph Caywood, the then controlling shareholder of JPX. The Company and Joseph Caywood have verbally agreed that the Company will pay the loan off as it is able to without penalty, and Joseph Caywood will not convert the debt into shares of common stock. As of September 30, 2017 and December 31, 2016, the balance of the loan is $1,500.

11

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

9 - DERIVATIVE LIABILITY

The derivative liability at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017
	Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	208,328	$	265,144
Totals	$	208,328	$	265,144
		December 31, 2016
		Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	166,000	$	724,364
Totals	$	166,000	$	724,364

The above convertible note contains a variable conversion feature based on the future trading price of the Company common stock. Therefore, the number of shares of commons stock issuable upon conversion of the note is indeterminate. Accordingly, we recorded the $730,400 fair value of the embedded conversion feature as a derivative liability at the July 22, 2016 issuance date and charged $166,000 to debt discounts and the remaining $564,400 to expense from derivative liability. The $465,256 decrease in the fair value of the derivative liability from $730,400 at July 22, 2016 to $265,144 at September 30, 2017 was credited to income from derivative liability ($6,036 in the year ended December 31, 2016 and $459,220 in the nine months ended September 30, 2017). The fair value of the derivative liability is measured at the respective issuance date and quarterly thereafter using the Black Scholes option pricing model. Assumptions used for the calculation of the derivative liability of the note at September 30, 2017 include (1) stock price of $0.002 per share, (2) exercise price of $0.00088 per share, (3) term of 0 days, (4) expected volatility of 117% and (5) risk free interest rate of 0.96%.

NOTE 10 - CAPITAL STOCK

On January 6, 2014, the Company issued 1,000 shares of Series A preferred stock as security for outstanding debts of the Company owed to Joseph Caywood. Although the preferred stock carried no dividend, distribution, liquidation or conversion rights, each share of Series A preferred stock carried one hundred thousand (100,000) votes, and holders of our Series A preferred stock are able to vote together with our common stockholders on all matters upon which common stockholders may vote. On July 12, 2017, the Company amended the Certificate of Designations, Preferences, Rights and Limitations of Series A Preferred Stock to change the voting rights of each share of Series A Preferred Stock to equal four times the sum of all shares of common stock issued and outstanding at time of voting plus the total number of votes of all other classes of preferred stock which are issued and outstanding at the time of voting divided by the number of shares of Series A Preferred Stock issued and outstanding at the time of voting.

12

JPX Global, Inc.

Notes to Financial Statements

September 30, 2017

(Unaudited)

On February 5, 2014 (see Note 1 above), the Company entered into an agreement to acquire all the operating assets of Scorpex, Inc. (“Scorpex”) (an entity related by common control) in exchange for 105,000,000 shares of common stock and 10,000,000 shares of Series B preferred stock of the Company. Scorpex was majority owned and controlled by JPX Global, Inc.’s former significant shareholder, Joseph Caywood. Each share of Series B preferred stock is convertible into 10 shares of common stock and is entitled to vote ratably together with our common stockholders on all matters upon which common stockholders may vote.

On February 17, 2015, pursuant to a Consulting Agreement with Joseph Caywood dated January 1, 2015 (term ended March 31, 2015), the Company issued a total of 2,050,000 shares of common stock to 18 individuals/entities for services rendered to the Company. The stock was valued at $2,050,000 and was expensed as consulting fees in the three months ended March 31, 2015.

On July 1, 2016, pursuant to a Consulting Services Agreement with an individual consultant dated June 1, 2016 (term ending November 30, 2016), the Company issued 2,000,000 shares of common stock to such individual for certain marketing consulting services to be rendered to the Company. The stock was valued at $400,000 and was expensed as consulting fees in the three months ended June 30, 2016.

On June 17, 2016, pursuant to a Consulting and Representation Agreement with an entity consultant dated June 14, 2016 (extended term ending June 14, 2017), the Company issued 1,000,000 shares of common stock to such entity for certain investor relations services to be rendered to the Company. The stock was valued at $200,000 and was expensed as consulting fees in the three months ended June 30, 2016.

During the three months ended March 31, 2017, the Company issued a total of 42,254,454 shares of common stock for the satisfaction of notes payable and accrued interest totaling $28,094.

NOTE 11 – SUBSEQUENT EVENTS

On January 22, 2018, the Company was named in a lawsuit along with 3 other defendants (i.e., Joseph Caywood, Scorpex, and a subsidiary of Scorpex). The plaintiff claims that he loaned money to and/or purchased stock from the Company and the other defendants and has not received repayment or stock that was promised. Plaintiff seeks damages in an amount to be determined at trial but in excess of $15,000, punitive damages in an amount to be determined at trial, attorney’s fees and costs of suit, and prejudgment and post-judgment interest on the amounts owed. The Company is currently in the process of preparing a response in defense of this lawsuit.

13

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition and results of operations of JPX Global, Inc. (hereafter, “JPEX”, the “Company,” “we,” “our,” or “us”) should be read in conjunction with the Unaudited Financial Statements and related Notes thereto included herein. This discussion may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, without limitation, statements regarding the Company’s expectations, beliefs, intentions, or future strategies that are signified by the words "expects," "anticipates," "intends," "believes," or similar language. Actual results could differ materially from those projected in the forward looking statements. Prospective investors should carefully consider the information set forth herein, and the Company cautions investors that its business and financial performance is subject to substantial risks and uncertainties.

Overview

On February 5, 2014, the Company entered into an agreement to acquire all of the operating assets of Scorpex, Inc., (“Scorpex”) (an entity related by common control) a Nevada corporation, in exchange for 105,000,000 shares of Common Stock and 10,000,000 shares of Series B Preferred Stock. Scorpex was majority owned and controlled by JPX Global, Inc.’s then controlling shareholder, Joseph Caywood. Each share of Series B preferred stock is convertible into 10 shares of common stock and is entitled to vote ratably together with our common stockholders on all matters upon which common stockholders may vote. The acquired assets consist primarily of a license agreement. We are now exploring the expansion of our business to further develop our operations to capitalize on the opportunities available primarily in Mexico, in the integrated waste, and waste management service operations, including the receiving, storage, transfer and disposal of waste in an environmental manner. In providing these services, we intend to actively pursue projects and initiatives that we believe make a positive difference for our environment which will be focused on gasification of waste in an environmental manner. It is expected that our customer base will include commercial, industrial, municipal and residential customers, other waste management companies, electric utilities, and governmental entity properties. We have not realized any revenues to date. We do not have sufficient capital to enable us to commence and complete our planned program. We will require additional financing in order to conduct the planned program described herein.Our auditors have issued a going concern opinion, raising substantial doubt about the Company's financial prospects, and the Company’s ability to continue as a going concern. As a waste management company, our principal sources of revenue will result from waste management contracts, but will also include revenue from ancillary services related to the handling and conversion of waste. Expenses which comprise the costs of goods sold will include the operational and staffing costs of the trucks and other vehicles used for transporting and special licensing where required. General and administrative expenses will include administrative wages and benefits; occupancy and office expenses; outside legal, accounting and other professional fees; travel and other miscellaneous office and administrative expenses. Selling and marketing expenses will include selling/marketing wages and benefits, advertising and promotional expenses, as well as travel and other miscellaneous related expenses.

The acquired assets consist primarily of a license agreement between Scorpex and TratamientosAmbientales Scorpion, S.A. de C.V. (a corporation formed under the laws of Mexico) (“TAS”). This license agreement with TAS has been assigned to JPX. TAS is a wholly owned subsidiary of Scorpex, and is, therefore, a common control entity. ASC 805-50-30-5 provides guidance on measuring assets and liabilities transferred between entities under common control. As these entities were under common control and the license agreement had no basis on Scorpex’s books, the transaction was recorded at a value of $-0-.

14

The future goal of the Company will be to develop a waste services division. The Company has modified its business plan to include the development of waste management services including the storage, recycling, and disposal of waste. 

Our ability to generate revenues during the year 2017 and beyond depends substantially upon the Company’s resources available in order to develop and grow the integrated waste and waste management businesses. Such efforts require significant systems development, marketing and personnel costs, which, in turn, require substantial funding. If we are unable to obtain such funding, our ability to generate revenues will be significantly impaired and we may be unable to continue operations.

Because the Company has incurred losses, income tax expenses are immaterial. No tax benefits have been booked related to operating loss carryforwards, given the uncertainty of the Company being able to utilize such loss carryforwards in future years. We anticipate incurring additional losses during the coming year.

Results of Operations

Following is management’s discussion of the relevant items affecting results of operations for the three and nine month periods ended September 30, 2017 and 2016.

Revenues. For the three and nine months ended September 30, 2017 and 2016, net revenues were $-0-. The Company expects to generate revenues with the acquisition of the waste management assets previously described. The Company hopes to commence operations during 2018.

Consulting Fees. Consulting fees for the three months ended September 30, 2017 were $-0- compared to $30,000 for the three months ended September 30, 2016. Consulting fees for the nine months ended September 30, 2017 were $-0- compared to $630,000 for the nine months ended September 30, 2016. During the nine months ended September 30, 2016 the Company issued 3,000,000 shares of common stock for services rendered to the Company. The shares were valued at $600,000 which represented the market price on the date of issuance.

Professional Fees. Professional fees for the three months ended September 30, 2017 were $12,279 compared to $90,105 for the three months ended September 30, 2016. Professional fees for the nine months ended September 30, 2017 were $37,293 compared to $113,313 for the nine months ended September 30, 2016. Professional fees consist mainly of the fees for the audits and reviews of the Company’s financial statements as well as the filings with the SEC. The Company anticipates that professional fees will increase commensurate with an increase in our operations.

Other General and Administrative Expenses. Other general and administrative expenses for the three months ended September 30, 2017 were $132 compared to $21,038 for the three months ended September 30, 2016. Other general and administrative expenses for the nine months ended September 30, 2017 were $396 compared to $21,832 for the nine months ended September 30, 2016. We expect that salaries and consulting expenses, that are cash- instead of share-based, will increase as we add personnel to build our waste management business.

15

Other Income (Expense). The Company had net other expense of $47,802 for the three months ended September 30, 2017 compared to net other expense of $179,179 for the three months ended September 30, 2016. The Company had net other income of $306,408 for the nine months ended September 30, 2017 compared to net other expense of $179,965 for the nine months ended September 30, 2016. For the nine months ended September 30, 2017, other expenses consisted of interest expense on promissory notes issued by the company in the amount of $152,811 which includes the amortization of debt discounts in the amount of $67,854. The Company also recorded income from derivative liability in the amount of $459,219.

Liquidity and Capital Resources

As of September 30, 2017, our primary source of liquidity consisted of $187 in cash and cash equivalents. Since inception, we have financed our operations through a combination of short term loans from related parties, notes payable, and through the private placement of our common stock. For the nine months ended September 30, 2017, we used $20,396 cash in operating activities and were provided $20,000 cash from financing activities.

We have sustained significant net losses which have resulted in an accumulated deficit at September 30, 2017 of $34,489,306 and are currently experiencing a substantial shortfall in operating capital which raises doubt about our ability to continue as a going concern. Historically, we have funded operating expenses through advances from related parties. We anticipate a net loss for the year ending December 31, 2017 and with the expected cash requirements for the coming months, without additional cash inflows from an increase in revenues or a receipt of cash from working capital loans or capital investment, there is substantial doubt as to the Company’s ability to continue operations.

There is presently no agreement in place with any source of additional financing for the Company and we cannot assure you that the Company will be able to raise any additional funds, or that such funds will be available on acceptable terms. Funds raised through future equity financing will likely be substantially dilutive to current shareholders. Lack of additional funds will materially affect the Company and its business, and may cause us to cease operations. Consequently, shareholders could incur a loss of their entire investment in the Company.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company we are not required to provide this information.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Report on Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, to allow for timely decisions regarding required disclosure.

As of September 30, 2017, the end of our quarter covered by this report, we carried out an evaluation, under the supervision of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, we concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.

16

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act, as amended). In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of control procedures. The objectives of internal control include providing management with reasonable, but not absolute, assurance that assets are safeguarded against loss from unauthorized use or disposition, and that transactions are executed in accordance with management’s authorization and recorded properly to permit the preparation of financial statements in conformity with accounting principles generally accepted in the United States. Our management assessed the effectiveness of our internal control over financial reporting as of September 30, 2017. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. Our management has concluded that, as of September 30, 2017, our internal control over financial reporting is effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with US generally accepted accounting principles. This quarterly report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this quarterly report.

Inherent limitations on effectiveness of controls

Internal control over financial reporting has inherent limitations which include but is not limited to the use of independent professionals for advice and guidance, interpretation of existing and/or changing rules and principles, segregation of management duties, scale of organization, and personnel factors. Internal control over financial reporting is a process which involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a timely basis, however these inherent limitations are known features of the financial reporting process and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There have been no significant changes in our internal controls over financial reporting that occurred during the quarter ended September 30, 2017 that have materially or are reasonably likely to materially affect, our internal controls over financial reporting.

17

PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company recently entered into a settlement agreement with Auctus Fund LLC ("Auctus") for a dispute regarding that certain Securities Purchase Agreement dated July 22, 2016. The Company did not have enough authorized shares available for conversion by Auctus. Auctus filed suit against the Company for breach of this Securities Purchase Agreement. The Company settled this lawsuit on August 8, 2017. The agreement provides for a $54,000 increase of the outstanding principal balance of the Note (from $154,328 to $208,328) and increasing the authorized number of shares and allowing for a reserve of shares to allow for future conversions attached herewith as Exhibit 10.1.

On January 22, 2018, the Company was named in a lawsuit along with 3 other defendants. The plaintiff claims that he loaned money to and/or purchased stock from the Company and has not received repayment or stock that was promised. The Company is currently in the process of preparing a response in defense of this lawsuit.

ITEM 1A. RISK FACTORS

As a smaller reporting company, we are not required to provide the information required by this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended March 31, 2017, the Company issued a total of 42,254,454 shares of common stock for the satisfaction of notes payable and accrued interest totaling $28,094.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

18

ITEM 6. EXHIBITS

The following documents are filed as exhibits to this Form 10-Q:

INDEX TO EXHIBITS

Number	Exhibits
3.1	Amended and Restated Articles of Incorporation (incorporated by reference from our report on Form 8-K filed on January 9, 2013).
3.2	Amended and Restated Bylaws (incorporated by reference from our report on Form 8-K filed on January 9, 2013).
10.1	Auctus Fund LLC- Settlement Agreement
31	Certification by Chief Executive Officer, Chene Gardner, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Certification by Chief Executive Officer, Chene Gardner, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

19

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	JPX GLOBAL, INC.
Date: March 29, 2018	By: /s/ Chene Gardner_____
	Chene Gardner
	Chief Executive Officer

20

EX-31

Exhibit 31

Certification of Chief Executive Officer and Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Chene Gardner, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2017 of JPX Global, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. As the registrant's certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

1. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

2. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

3. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

4. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

1. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

2. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: March 29, 2018

By: /s/ Chene Gardner

Chene Gardner

Chief Executive Officer

and Principal Financial Officer

EX-32

Exhibit 32

Certification of Chief Executive Officer and Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Chene Gardner, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the quarterly report on Form 10-Q for the quarterly period ended September 30, 2017 of JPX Global, Inc. fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of JPX Global, Inc.

Date: March 29, 2018

By: /s/ Chene Gardner

Chene Gardner

Chief Executive Officer

and Principal Financial Officer

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Mar. 21, 2018
Document And Entity Information
Entity Registrant Name	JPX Global Inc.
Entity Central Index Key	0001506814
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		214,043,596
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2017

XML

Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 187	$ 583
Total Current Assets	187	583
TOTAL ASSETS	187	583
CURRENT LIABILITIES
Accounts payable and accrued liabilities	79,818	47,989
Advances from related parties	21,594	14,594
Notes payable to related parties	184,864	171,864
Notes payable	258,328	148,146
Convertible loan payable - related party	1,500
Derivative liability	265,144	724,364
Total Current Liabilities	811,248	1,108,457
TOTAL LIABILITIES	811,248	1,108,457
Preferred stock, $0.001 par value; 40,000,000 shares authorized:
Common stock	214,043	171,789
Additional paid-in capital	33,454,201	33,468,361
Accumulated deficit	(34,489,306)	(34,758,025)
Total Stockholders' Deficit	(811,061)	(1,107,874)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	187	583
Series A Preferred Stock
Preferred stock, $0.001 par value; 40,000,000 shares authorized:
Preferred stock	1	1
Series B Preferred Stock
Preferred stock, $0.001 par value; 40,000,000 shares authorized:
Preferred stock	$ 10,000	$ 10,000

XML

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	40,000,000	40,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	214,043,596	171,789,142
Common stock, shares outstanding	214,043,596	171,789,142
Series A Preferred Stock
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares issued	1,000	1,000
Preferred Stock, shares outstanding	1,000	1,000
Series B Preferred Stock
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares issued	10,000,000	10,000,000
Preferred Stock, shares outstanding	10,000,000	10,000,000

XML

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
NET REVENUES	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Consulting fees	0	30,000	0	630,000
Professional and accounting fees	12,279	90,105	37,293	113,313
Other general and administrative	132	21,038	396	21,832
Total Operating Expenses	12,411	141,143	37,689	765,145
LOSS FROM OPERATIONS	(12,411)	(141,143)	(37,689)	(765,145)
OTHER INCOME (EXPENSES)
Income (loss) from derivative liability	15,451	(127,971)	459,219	(127,971)
Interest expense	(63,253)	(51,208)	(152,811)	(51,994)
Total Other Income (Expenses)	(47,802)	(179,179)	306,408	(179,965)
NET INCOME (LOSS)	$ (60,213)	$ (320,322)	$ 268,719	$ (945,110)
Net income (loss) per common share - basic and diluted	$ (0.00)	$ (0.00)	$ 0.00	$ (0.01)
Weighted average common shares outstanding: Basic	214,043,596	170,455,809	204,520,333	168,733,181
Weighted average common shares outstanding: Diluted	214,043,596	170,455,809	542,756,310	168,733,181

XML

Statements of Operations (Parenthetical) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Stock-based compensation	$ 0	$ 0	$ 0	$ 600,000
Amortization of debt discounts	$ 0	$ 42,409	$ 67,854	$ 42,409

XML

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 268,719	$ (945,110)
Adjustments to reconcile net loss to net cash used by operating activities:
Common stock issued for services	0	600,000
Note payable issued for legal services	0	50,000
Default fees added to notes payable	54,000	0
Amortization of debt discount	67,854	42,409
Expense (income) from derivative liability	(459,219)	127,971
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	48,250	8,427
Net Cash Used by Operating Activities	(20,396)	(116,303)
CASH FLOWS FROM INVESTING ACTIVITIES:	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from note payable	0	166,000
Proceeds from notes payable to related party	13,000	5,000
Proceeds from advances from related party	7,000	11,500
Payments on note payable to related party	0	(66,200)
Net Cash Provided by Financing Activities	20,000	116,300
NET DECREASE IN CASH AND CASH EQUIVALENTS	(396)	(3)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	583	83
CASH AND CASH EQUIVALENTS, END OF PERIOD	187	80
SUPPLEMENTAL CASH FLOW INFORMATION
Interest	0	0
Taxes	0	0
Non-cash financing activities:
Common stock issued for services	0	600,000
Issuance of note payable to related party in satisfaction of advances from related party liability	0	254,364
Issuance of common stock in satisfaction of notes payable and accrued interest	$ 28,094	$ 0

XML

NOTE 1 - ORGANIZATION

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

NOTE 1 - ORGANIZATION

NOTE 1 - ORGANIZATION

JPX Global, Inc. (the “Company” or “JPX”) was incorporated under the laws of the state of Nevada on December 18, 2008, with 75,000,000 authorized common shares with a par value of $0.001. On January 3, 2013, the Company approved the action to amend and restate the Articles of Incorporation of the Company and increase the authorized common shares to 500,000,000 and create and authorize 40,000,000 shares of Preferred Stock which was approved by written consent of the holders representing approximately 67% of the outstanding voting securities of the Company. Series A Preferred Stock was created and designated with super-voting rights of 100,000 votes per share of Series A Preferred Stock held, but no conversion, dividend and liquidation rights. On July 12, 2017, the Company amended the Certificate of Designations, Preferences, Rights and Limitations of Series A Preferred Stock to change the voting rights of each share of Series A Preferred Stock to equal four times the sum of all shares of common stock issued and outstanding at time of voting plus the total number of votes of all other classes of preferred stock which are issued and outstanding at the time of voting divided by the number of shares of Series A Preferred Stock issued and outstanding at the time of voting. On August 29, 2017, the Company amended its Articles of Incorporation to increase the authorized common shares to 1,500,000,000 shares.

On February 5, 2014, the Company entered into an agreement to acquire all the operating assets of Scorpex, Inc. (“Scorpex”) (an entity related by common control) in exchange for 105,000,000 shares of common stock and 10,000,000 shares of Series B Preferred Stock of the Company. Scorpex was majority owned and controlled by JPX Global, Inc.’s then controlling shareholder, Joseph Caywood. Each share of Series B preferred stock is convertible into 10 shares of common stock and is entitled to vote ratably together with our common stockholders on all matters upon which common stockholders may vote. With the acquisition of these assets, which consist primarily of a license agreement, the Company modified its business plan to include the development of waste management services including the storage, recycling, and disposal of waste.  The Company does not presently have any waste management operations.

The acquired assets consist primarily of a license agreement between Scorpex and TratamientosAmbientales Scorpion, S.A. de C.V. (a corporation formed under the laws of Mexico) (“TAS”). This license agreement with TAS was assigned to JPX. TAS was a wholly owned subsidiary of Scorpex, and was, therefore, a common control entity. ASC 805-50-30-5 provides guidance on measuring assets and liabilities transferred between entities under common control. As these entities were under common control and the license agreement had no basis on Scorpex’s books, the transaction was recorded at a value of $-0-.

The license agreement was dated July 30, 2011 and provided Scorpex with an exclusive worldwide license for the permits, property, and any and all of TAS’s other assets necessary for the business of storing, recycling, disposing, and treating waste in Mexico for a term of 10 years. The agreement also provided for Scorpex’s annual payment to TAS of 20% of its Net Revenues (gross cash receipts less cost of processing and other expenses excluding general, administrative, interest, and taxes) from the license. Pursuant to the Assignment Consent dated February 3, 2014, TAS agreed to extend the term of the agreement every 10 years if operations have commenced pursuant to the license agreement.

XML

NOTE 2 - BASIS OF FINANCIAL STATEMENT PRESENTATION

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NOTE 2 - BASIS OF FINANCIAL STATEMENT PRESENTATION

NOTE 2 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its Form 10-K for the year ended December 31, 2016. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017.

XML

NOTE 3 - GOING CONCERN

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN

The accompanying financial statements have been prepared assuming that the company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. At September 30, 2017, the Company had $187 cash, negative working capital of $811,061 (including past due debt), and no business operations. These conditions raise substantial doubt about our ability to meet our future financial obligations as they become due within one year after the date that the financial statements are issued.

Continuation of the company as a going concern is dependent upon obtaining additional working capital and the management of the company plans to accomplish this objective through short term loans from related parties and additional equity investments, which will enable the company to continue operations for the coming year. However, no financing arrangements have yet been implemented. Therefore, these plans do not alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year after the date that the financial statements are issued.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from the outcome of this uncertainty.

XML

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE

The Company follows ASC Topic 260 to account for earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share calculations are determined by dividing net income (loss) by the weighted average number of common shares and dilutive common share equivalents outstanding.

For the periods presented, the common shares underlying the following dilutive securities were excluded from the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive:

	Common Shares Issuable
	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2016
Convertible note payable		236,735,977		6,036,364		6,036,364
Convertible loan payable – related party		1,500,000		1,500,000		1,500,000
Series B Preferred Stock		100,000,000		100,000,000		100,000,000
Total common shares issuable		338,235,977		107,536,364		107,536,364

XML

NOTE 5 - ADVANCES FROM RELATED PARTIES

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

NOTE 5 - ADVANCES FROM RELATED PARTIES

NOTE 5 - ADVANCES FROM RELATED PARTIES

The advances from related parties liability at September 30, 2017 ($21,594) and December 31, 2016 ($14,594) are due to Joseph Caywood, former chief executive officer and significant stockholder of the Company, and John D. Thomas PC, legal counsel of the Company. The liabilities are non-interest bearing and there are no terms of repayment.

On July 1, 2016, the Company issued a $254,364 Promissory Note to Joseph Caywood in satisfaction of the then advances from related party liability of $254,364. See Note 6.

XML

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES

The notes payable to related parties at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017		December 31, 2016
Promissory note dated May 20, 2015, interest at 8% per annum, interest and principal due November 20, 2015 (A)	$	8,000	$	8,000
Promissory note dated June 24, 2015, interest at 8% per annum, interest and principal due December 24, 2015 (A)		8,000		8,000
Promissory note dated November 15, 2015, interest at 8% per annum, interest and principal due May 15, 2016 (A)		2,000		2,000
Promissory note dated April 15, 2016, interest at 8% per annum, interest and principal due October 12, 2016 (A)		3,000		3,000
Promissory note dated May 21, 2016, interest at 8% per annum, interest and principal due November 17, 2016 (A)		2,000		2,000
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		148,864		148,864
Promissory note dated August 9, 2017, interest at 8% per annum, interest and principal due February 9, 2019 (A)		6,500		—
Promissory note dated September 8, 2017, interest at 8% per annum, interest and principal due March 8, 2019 (A)		6,500		—
Total	$	184,864	$	171,864

(A) These notes are payable to Mitchell Dean Hovendick, owner of 1,000 shares of Series A Preferred Stock, 10,000,000 shares of Series B Preferred Stock, and 75,250,000 shares of common stock.

(B) This note is payable to Joseph Caywood, former owner of 500 shares of Series A Preferred Stock, 5,000,000 shares of Series B Preferred Stock, and 37,625,000 shares of common stock. The original note was in the amount of $254,364 and arose from the Company’s satisfaction of the then advances from related party liability of $254,364 (See Note 5). From July 1, 2016 to December 31, 2016, the Company repaid $105,500 of the note.

XML

NOTE 7 - NOTES PAYABLE

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

NOTE 7 - NOTES PAYABLE

NOTE 7 – NOTES PAYABLE

The notes payable at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017		December  31, 2016
Convertible note payable dated July 22, 2016, interest at 10% due on April 22, 2017 – net of discount of $-0- and $67,854, respectively (A)	$	208,328	$	98,146
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		50,000		50,000
Total	$	258,328	$	148,146

(A) On July 22, 2016, the Company issued a $166,000 Convertible Promissory Note to Auctus Fund, LLC (“Auctus”) for net loan proceeds of $150,000. The note bears interest at a rate of 10% per annum (24% per annum default rate), is due April 22, 2017, and is convertible at the option of Auctus into shares of the Company common stock at a Conversion Price equal to the lesser of (a) 55% of the lowest Trading Price during the 25 Trading Day period prior to July 22, 2016 or (b) 55% of the lowest Trading Price during the 25 Trading Day period prior to the Conversion Date. See Note 9 – Derivative Liability. On August 8, 2017, the Company entered into a Settlement Agreement and Mutual General Release with Auctus. The agreement provided for a $54,000 increase of the outstanding principal balance of the Note (from $154,328 to $208,328). The agreement also provided for the Company’s issuance of an irrevocable letter of instruction to its transfer agent to reserve initially 933,333,334 shares of common stock for conversion of the Amended Note.

(B) This note is payable to the Company’s law firm for legal services rendered.

XML

NOTE 8 - CONVERTIBLE LOAN PAYABLE - RELATED PARTY

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

NOTE 8 - CONVERTIBLE LOAN PAYABLE - RELATED PARTY

NOTE 8 - CONVERTIBLE LOAN PAYABLE - RELATED PARTY

On December 18, 2008, the Company entered into a Promissory Note agreement with a former CEO of the Company. The note is for a sum of $1,500, is non interest bearing, and was due and payable on December 31, 2010. The note provides that if the note was not paid on December 31, 2010, the note can be converted to shares of common stock of the Company for $.001 per share. On January 3, 2013, this note was assigned to Joseph Caywood, the then controlling shareholder of JPX. The Company and Joseph Caywood have verbally agreed that the Company will pay the loan off as it is able to without penalty, and Joseph Caywood will not convert the debt into shares of common stock. As of September 30, 2017 and December 31, 2016, the balance of the loan is $1,500.

XML

NOTE 9 - DERIVATIVE LIABILITY

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

NOTE 9 - DERIVATIVE LIABILITY

9 - DERIVATIVE LIABILITY

The derivative liability at September 30, 2017 and December 31, 2016 consisted of the following:

	September 30, 2017
	Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	208,328	$	265,144
Totals	$	208,328	$	265,144
		December 31, 2016
		Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	166,000	$	724,364
Totals	$	166,000	$	724,364

The above convertible note contains a variable conversion feature based on the future trading price of the Company common stock. Therefore, the number of shares of commons stock issuable upon conversion of the note is indeterminate. Accordingly, we recorded the $730,400 fair value of the embedded conversion feature as a derivative liability at the July 22, 2016 issuance date and charged $166,000 to debt discounts and the remaining $564,400 to expense from derivative liability. The $465,256 decrease in the fair value of the derivative liability from $730,400 at July 22, 2016 to $265,144 at September 30, 2017 was credited to income from derivative liability ($6,036 in the year ended December 31, 2016 and $459,220 in the nine months ended September 30, 2017). The fair value of the derivative liability is measured at the respective issuance date and quarterly thereafter using the Black Scholes option pricing model. Assumptions used for the calculation of the derivative liability of the note at September 30, 2017 include (1) stock price of $0.002 per share, (2) exercise price of $0.00088 per share, (3) term of 0 days, (4) expected volatility of 117% and (5) risk free interest rate of 0.96%.

XML

NOTE 10 - CAPITAL STOCK

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

NOTE 10 - CAPITAL STOCK

NOTE 10 - CAPITAL STOCK

On January 6, 2014, the Company issued 1,000 shares of Series A preferred stock as security for outstanding debts of the Company owed to Joseph Caywood. Although the preferred stock carried no dividend, distribution, liquidation or conversion rights, each share of Series A preferred stock carried one hundred thousand (100,000) votes, and holders of our Series A preferred stock are able to vote together with our common stockholders on all matters upon which common stockholders may vote. On July 12, 2017, the Company amended the Certificate of Designations, Preferences, Rights and Limitations of Series A Preferred Stock to change the voting rights of each share of Series A Preferred Stock to equal four times the sum of all shares of common stock issued and outstanding at time of voting plus the total number of votes of all other classes of preferred stock which are issued and outstanding at the time of voting divided by the number of shares of Series A Preferred Stock issued and outstanding at the time of voting.

On February 5, 2014 (see Note 1 above), the Company entered into an agreement to acquire all the operating assets of Scorpex, Inc. (“Scorpex”) (an entity related by common control) in exchange for 105,000,000 shares of common stock and 10,000,000 shares of Series B preferred stock of the Company. Scorpex was majority owned and controlled by JPX Global, Inc.’s former significant shareholder, Joseph Caywood. Each share of Series B preferred stock is convertible into 10 shares of common stock and is entitled to vote ratably together with our common stockholders on all matters upon which common stockholders may vote.

On February 17, 2015, pursuant to a Consulting Agreement with Joseph Caywood dated January 1, 2015 (term ended March 31, 2015), the Company issued a total of 2,050,000 shares of common stock to 18 individuals/entities for services rendered to the Company. The stock was valued at $2,050,000 and was expensed as consulting fees in the three months ended March 31, 2015.

On July 1, 2016, pursuant to a Consulting Services Agreement with an individual consultant dated June 1, 2016 (term ending November 30, 2016), the Company issued 2,000,000 shares of common stock to such individual for certain marketing consulting services to be rendered to the Company. The stock was valued at $400,000 and was expensed as consulting fees in the three months ended June 30, 2016.

On June 17, 2016, pursuant to a Consulting and Representation Agreement with an entity consultant dated June 14, 2016 (extended term ending June 14, 2017), the Company issued 1,000,000 shares of common stock to such entity for certain investor relations services to be rendered to the Company. The stock was valued at $200,000 and was expensed as consulting fees in the three months ended June 30, 2016.

During the three months ended March 31, 2017, the Company issued a total of 42,254,454 shares of common stock for the satisfaction of notes payable and accrued interest totaling $28,094.

XML

NOTE 11 - SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

NOTE 11 - SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

On January 22, 2018, the Company was named in a lawsuit along with 3 other defendants (i.e., Joseph Caywood, Scorpex, and a subsidiary of Scorpex). The plaintiff claims that he loaned money to and/or purchased stock from the Company and the other defendants and has not received repayment or stock that was promised. Plaintiff seeks damages in an amount to be determined at trial but in excess of $15,000, punitive damages in an amount to be determined at trial, attorney’s fees and costs of suit, and prejudgment and post-judgment interest on the amounts owed. The Company is currently in the process of preparing a response in defense of this lawsuit.

XML

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Dilutive securities

	Common Shares Issuable
	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2016
Convertible note payable		236,735,977		6,036,364		6,036,364
Convertible loan payable – related party		1,500,000		1,500,000		1,500,000
Series B Preferred Stock		100,000,000		100,000,000		100,000,000
Total common shares issuable		338,235,977		107,536,364		107,536,364

XML

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES (Tables)

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

Notes payable - related parties

	September 30, 2017		December 31, 2016
Promissory note dated May 20, 2015, interest at 8% per annum, interest and principal due November 20, 2015 (A)	$	8,000	$	8,000
Promissory note dated June 24, 2015, interest at 8% per annum, interest and principal due December 24, 2015 (A)		8,000		8,000
Promissory note dated November 15, 2015, interest at 8% per annum, interest and principal due May 15, 2016 (A)		2,000		2,000
Promissory note dated April 15, 2016, interest at 8% per annum, interest and principal due October 12, 2016 (A)		3,000		3,000
Promissory note dated May 21, 2016, interest at 8% per annum, interest and principal due November 17, 2016 (A)		2,000		2,000
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		148,864		148,864
Promissory note dated August 9, 2017, interest at 8% per annum, interest and principal due February 9, 2019 (A)		6,500		—
Promissory note dated September 8, 2017, interest at 8% per annum, interest and principal due March 8, 2019 (A)		6,500		—
Total	$	184,864	$	171,864

XML

NOTE 7 - NOTES PAYABLE (Tables)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Notes payable

	September 30, 2017		December  31, 2016
Convertible note payable dated July 22, 2016, interest at 10% due on April 22, 2017 – net of discount of $-0- and $67,854, respectively (A)	$	208,328	$	98,146
Promissory note dated July 1, 2016, interest at 8% per annum, interest and principal due on demand (B)		50,000		50,000
Total	$	258,328	$	148,146

XML

NOTE 9 - DERIVATIVE LIABILITY (Tables)

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Derivative liability

	September 30, 2017
	Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	208,328	$	265,144
Totals	$	208,328	$	265,144
		December 31, 2016
		Face Value		Derivative Liability
Convertible note payable issued July 22, 2016, due April 22, 2017	$	166,000	$	724,364
Totals	$	166,000	$	724,364

XML

NOTE 4 - NET INCOME (LOSS) PER COMMON SHARE - Dilutive securities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2016
Convertible loan payable – related party	$ 1,500
Common shares issuable
Convertible note payable	236,735,977	$ 6,036,364	$ 6,036,364
Convertible loan payable – related party	$ 1,500,000	$ 1,500,000	$ 1,500,000
Series B Preferred Stock	100,000,000	100,000,000	100,000,000
Total common shares issuable	338,235,977	107,536,364	107,536,364

XML

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES - Notes payable - related parties (Details) - USD ($)	Sep. 30, 2017	Sep. 30, 2016
Notes payable	$ 1,500
Promissory note dated May 20, 2015
Notes payable	8,000	$ 8,000
Promissory note dated June 24, 2015
Notes payable	8,000	8,000
Promissory note dated November 15, 2015
Notes payable	2,000	2,000
Promissory note dated April 15, 2016
Notes payable	3,000	3,000
Promissory note dated May 21, 2016
Notes payable	2,000	2,000
Promissory note dated July 1, 2016
Notes payable	148,864	148,864
Promissory note dated August 9, 2017
Notes payable	6,500	0
Promissory note dated September 8, 2017
Notes payable	$ 6,500	$ 0

XML

NOTE 7 - NOTES PAYABLE - Notes payable (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Notes payable	$ 258,328	$ 148,146
Convertible note payable dated July 22,2016
Notes payable	208,328	98,146
Promissory note dated July 1, 2016
Notes payable	$ 50,000	$ 50,000

XML

9 - DERIVATIVE LIABILITY - Derivative liability (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Notes to Financial Statements
Face value	$ 280,596	$ 166,000
Derivative liability	$ 265,144	$ 724,364

XML

NOTE 5 - ADVANCES FROM RELATED PARTIES (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Joseph Caywood
Promissory note issued		$ 254,364
Advances from related party	$ (21,594)	$ 254,364
John D. Thomas PC
Advances from related party	$ (145,594)

XML

NOTE 6 - NOTES PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)	6 Months Ended	9 Months Ended
	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Common stock shares, issued	171,789,142	214,043,596
Advances from related party	$ 14,594	$ 21,594
Payment on note		$ 0	$ 66,200
Mitch Dean Hovendick
Common stock shares, issued		75,250,000
Mitch Dean Hovendick (Series A Preferred Stock)
Preferred stock shares, issued		1,000
Mitch Dean Hovendick (Series B Preferred Stock)
Preferred stock shares, issued		10,000,000
Joseph Caywood
Common stock shares, issued		37,625,000
Advances from related party		$ 254,364
Payment on note	$ 105,500
Joseph Caywood (Series A Preferred Stock)
Preferred stock shares, issued		500
Joseph Caywood (Series B Preferred Stock)
Preferred stock shares, issued		5,000,000

XML

NOTE 7 - NOTES PAYABLE (Details Narrative)

9 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Note payable

On July 22, 2016, the Company issued a $166,000 Convertible Promissory Note to Auctus Fund, LLC (“Auctus”) for net loan proceeds of $150,000. The note bears interest at a rate of 10% per annum (24% per annum default rate), is due April 22, 2017, and is convertible at the option of Auctus into shares of the Company common stock at a Conversion Price equal to the lesser of (a) 55% of the lowest Trading Price during the 25 Trading Day period prior to July 22, 2016 or (b) 55% of the lowest Trading Price during the 25 Trading Day period prior to the Conversion Date. See Note 9 – Derivative Liability. On August 8, 2017, the Company entered into a Settlement Agreement and Mutual General Release with Auctus. The agreement provided for a $54,000 increase of the outstanding principal balance of the Note (from $154,328 to $208,328). The agreement also provided for the Company’s issuance of an irrevocable letter of instruction to its transfer agent to reserve initially 933,333,334 shares of common stock for conversion of the Amended Note.

XML

NOTE 8. CONVERTIBLE LOAN PAYABLE - RELATED PARTY (Details Narrative) - Promissory Note (1) - USD ($)

114 Months Ended

Jun. 30, 2017

Dec. 18, 2008

Convertible notes payable - related party

$ 1,500

Terms of convertible note

On December 18, 2008, the Company entered into a Promissory Note agreement with a former CEO of the Company. The note is for a sum of $1,500, is non interest bearing, and was due and payable on December 31, 2010. The note provides that if the note was not paid on December 31, 2010, the note can be converted to shares of common stock of the Company for $.001 per share. On January 3, 2013, this note was assigned to Joseph Caywood, the then controlling shareholder of JPX. The Company and Joseph Caywood have verbally agreed that the Company will pay the loan off as it is able to without penalty, and Joseph Caywood will not convert the debt into shares of common stock. As of September 30, 2017 and December 31, 2016, the balance of the loan is $1,500.

XML

NOTE 9 - DERIVATIVE LIABILITY (Details Narrative)

3 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Convertible note

The above convertible note contains a variable conversion feature based on the future trading price of the Company common stock. Therefore, the number of shares of commons stock issuable upon conversion of the note is indeterminate. Accordingly, we recorded the $730,400 fair value of the embedded conversion feature as a derivative liability at the July 22, 2016 issuance date and charged $166,000 to debt discounts and the remaining $564,400 to expense from derivative liability. The $465,256 decrease in the fair value of the derivative liability from $730,400 at July 22, 2016 to $265,144 at September 30, 2017 was credited to income from derivative liability ($6,036 in the year ended December 31, 2016 and $459,220 in the nine months ended September 30, 2017). The fair value of the derivative liability is measured at the respective issuance date and quarterly thereafter using the Black Scholes option pricing model. Assumptions used for the calculation of the derivative liability of the note at September 30, 2017 include (1) stock price of $0.002 per share, (2) exercise price of $0.00088 per share, (3) term of 0 days, (4) expected volatility of 117% and (5) risk free interest rate of 0.96%.

XML

NOTE 10 - CAPITAL STOCK (Details Narrative) - USD ($)	Sep. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Jun. 17, 2016	Feb. 05, 2016	Jan. 06, 2016	Feb. 17, 2015
Common stock, issued	214,043,596		171,789,142
Common stock, value	$ 214,043		$ 171,789
Stock issued to Joseph Caywood
Preferred stock, issued						1,000
Agreement to acquire the assets of Scorpex, Inc.
Preferred stock, issued					10,000,000
Common stock, issued					105,000,000
Consulting Agreement with Joseph Caywood
Common stock, issued							2,050,000
Common stock, value							$ 2,050,000
Consulting Services Agreement with an individual consultant on July 1, 2016
Common stock, issued			2,000,000
Common stock, value			$ 400,000
Consulting and Representative Agreement with an entity consultant
Common stock, issued				1,000,000
Common stock, value				$ 200,000
Satisfaction of notes payable and accrued interest
Common stock, issued		42,254,454
Common stock, value		$ 28,094

XML

NOTE 11 - SUBSEQUENT EVENTS (Details Narrative)

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Settlement Agreement and Mutual Release

On January 22, 2018, the Company was named in a lawsuit along with 3 other defendants (i.e., Joseph Caywood, Scorpex, and a subsidiary of Scorpex). The plaintiff claims that he loaned money to and/or purchased stock from the Company and the other defendants and has not received repayment or stock that was promised. Plaintiff seeks damages in an amount to be determined at trial but in excess of $15,000, punitive damages in an amount to be determined at trial, attorney’s fees and costs of suit, and prejudgment and post-judgment interest on the amounts owed. The Company is currently in the process of preparing a response in defense of this lawsuit.